Germany, March 4 -- Germany based Hexal AG, Hikma Pharma GmbH, kohlpharma GmbH, Demo Pharmaceuticals GmbH, Grindeks Kalceks Deutschland GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Meropenem, ATC J01DH02 for the period 01032024 - 28022026. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....